TITLE

Artificial neural network is superior to MELD in predicting mortalily of patients with end-stage liver disease

AUTHOR(S)
Cucchetti, A.; Vivarelli, M.; Heaton, N. D.; Phillips, S.; Piscaglia, F.; Bolondi, I.; La Barba, G.; Foxton, M. R.; Rela, M.; O'Grady, J.; A. D. Pinna
PUB. DATE
February 2007
SOURCE
Gut;Feb2007, Vol. 56 Issue 2, p253
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Despite its accuracy, the model for end-stage liver disease (MELD), currently adopted to determine the prognosis of patients with liver cirrhosis, guide referral to transplant programmes and prioritise the allocation of donor organs, fails to predict mortality in a considerable proportion of patients. Aims: To evaluate the possibility to better predict 3-month liver disease-related mortality of patients awaiting liver transplantation using an artificial neural network (ANN). Patients and methods: The ANN was constructed using data from 251 consecutive people with cirrhosis listed for liver transplantation at the Liver Transplant Unit, Bologna, Italy. The ANN was trained to predict 3-month survival on 188 patients, tested on the remaining 63 (internal validation group) unknown by the system and finally on 137 patients listed for liver transplantation at the King's College Hospital, London, UK (external cohort). Predictions of survival obtained with ANN and MELD on the same datasets were compared using areas under receiver-operating characteristic (ROC) curves (AUC). Results: The ANN performed significantly better than MELD both in the internal validation group (AUC = 0.95 v 0.85; p=0.032) and in the external cohort (AUC=0.96 v 0.86; p =0.044). Conclusions: The ANN measured the mortality risk of patients with cirrhosis more accurately than MELD and could better prioritise liver transplant candidates, thus reducing mortality in the waiting list.
ACCESSION #
24040269

 

Related Articles

  • Prognostic limitations of the Eurotransplant-donor risk index in liver transplantation. Reichert, Benedikt; Kaltenborn, Alexander; Goldis, Alon; Schrem, Harald // Journal of Negative Results in Biomedicine;2013, Vol. 12 Issue 1, p1 

    Background Liver transplantation is the only life-saving therapeutic option for end-stage liver disease. Progressive donor organ shortage and declining donor organ quality justify the evaluation of the leverage of the Donor-Risk-Index, which was recently adjusted to the Eurotransplant...

  • Improving Survival in Decompensated Cirrhosis. Nath Mukerji, Amar; Patel, Vishal; Jain, Ashokkumar // International Journal of Hepatology;2012, p1 

    Mortality in cirrhosis is consequent of decompensation, only treatment being timely liver transplantation. Organ allocation is prioritized for the sickest patients based on Model for End Stage Liver Disease (MELD) score. In order to improve survival in patients with high MELD score it is...

  • Evolution of living donor liver transplantation over 10 years: Experience of a single center. Eguchi, Susumu; Takatsuki, Mitsuhisa; Hidaka, Masaaki; Tajima, Yoshitsugu; Kanematsu, Takashi // Surgery Today;Sep2008, Vol. 38 Issue 9, p795 

    Purpose: To evaluate the changes in living donor liver transplantations (LDLTs) over the last 10 years, we analyzed our experience of performing LDLT in a single center. Methods: We performed 73 LDLTs over the 10 years between 1997 and 2007 in Nagasaki University Hospital, Japan. Results:...

  • Vermittlung postmortal gespendeter Lebern. Rahmel, A. // Der Chirurg;May2013, Vol. 84 Issue 5, p372 

    Eurotransplant is responsible for the allocation of organs from deceased donors in Germany. The guidelines governing this allocation process have been developed and are continuously updated by the German Medical Association and are based on urgency and outcome of the planned transplantation. The...

  • Liver transplantation in the high MELD era: a fair chance for everyone? Bahra, Marcus; Neuhaus, Peter // Langenbeck's Archives of Surgery;Apr2011, Vol. 396 Issue 4, p461 

    Introduction: In 2006, the model for end-stage liver disease (MELD) was introduced in Germany. Recent data clearly show a decrease of mortality on the waiting list but also a decrease of post-liver transplant survival. Several factors are discussed to be responsible for that; although, a MELD...

  • The evolution in the prioritization for liver transplantation. Cholongitasa, Evangelos; Burroughsb, Andrew K. // Annals of Gastroenterology;Jan2012, Vol. 25, p6 

    Policies for organ allocation can be based on medical urgency, utility or transplant benefit. With an urgency policy, patients with worse outcomes on the waiting list are given higher priority for transplantation [based on the Child--Turcotte--Pugh score or the Model for End-stage Liver Disease...

  • Hepatopulmonary syndrome: Is it time to redefine the MELD exception score for better organ allocation and outcomes? Porres-Aguilar, Mateo; Gallegos-Orozco, Juan Fernando // Annals of Hepatology: Official Journal of the Mexican Associatio;Jul/Aug2014, Vol. 13 Issue 4, p468 

    The article presents the author's views on hepatopulmonary syndrome and redefining the model of end-stage liver disease (MELD) exception score for better organ allocation and outcomes. It discusses the impact of the MELD exception policy on liver transplantation patients' outcome. The author...

  • The Nutritional Index 'CONUT' Is Useful for Predicting Long-Term Prognosis of Patients with End-Stage Liver Diseases. Fukushima, Koji; Ueno, Yoshiyuki; Kawagishi, Naoki; Kondo, Yasuteru; Inoue, Jun; Kakazu, Eiji; Ninomiya, Masashi; Wakui, Yuta; Saito, Naoko; Satomi, Susumu; Shimosegawa, Tooru // Tohoku Journal of Experimental Medicine;Jul2011, Vol. 224 Issue 3, p215 

    Organ allocation in Japan remains dificult due to the shortage of deceased-donor livers. The screening tool for controlling nutritional status (CONUT) has been considered to be an established assessment model for evaluating nutritional aspects in surgical patients. However, the application of...

  • Factors Prognostic of Survival in Patients Awaiting Liver Transplantation for End-Stage Liver Disease. Haldun Selcuk; Irfan Uruc; Mehtap Temel; Serkan Ocal; Bulent Huddam; Murat Korkmaz; Hakan Unal; Nurten Savas; Gurden Gur; Ugur Yilmaz; Mehmet Haberal // Digestive Diseases & Sciences;Nov2007, Vol. 52 Issue 11, p3217 

    Abstract  In this study, we investigated possible independent predictive factors for survival, other than MELD score, in patients with cirrhosis. We reviewed the serum sodium, cholesterol, albumin, and platelet levels of 99 patients with cirrhosis and investigated the possible...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics